Industry

DUBLIN–(BUSINESS WIRE)–The “Primary Sclerosing Cholangitis (PSC) – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Primary Sclerosing Cholangitis (PSC)- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Primary Sclerosing Cholangitis (PSC), historical and forecasted epidemiology as well as the Primary Sclerosing Cholangitis (PSC) … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Graves Disease – Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This “Graves Disease – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Graves Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and … [Read more…]

Recognizing 10 Life Science Trailblazers Under the Age of 40 Across California SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the California life science industry, today called for entries for the seventh annual Life Science Catalyst Awards from the San Francisco Bay Area, San Diego and Los Angeles … [Read more…]

First-of-its-kind platform provides publicly-accessible, quarterly data trends on adult vaccination to strengthen data transparency and empower the public health community with actionable information Vaccine Track data insights revealed sustained decline of recommended adult immunizations, excluding flu vaccinations, across the US during the pandemic, especially in minority populations PHILADELPHIA–(BUSINESS WIRE)–GSK plc (LSE/NYSE: GSK) today announced the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Point-of-Care Molecular Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis” report has been added to ResearchAndMarkets.com’s offering. The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to … [Read more…]

As WHO declares a global health emergency, 65% of doctors say their countries do not have enough vaccines NEW YORK–(BUSINESS WIRE)–With the spread of monkeypox on the rise and the World Health Organization (WHO) declaring a global health emergency, findings from a recent survey conducted by Sermo, a physician-first online community and leader in global … [Read more…]

Indications for Use Include Surgery on Foot/Ankle, Shoulder, Knee, Hand/Wrist and Elbow Advantages Over Traditional Anchors Include Self-Tapping Insertion Strength, Superior Pull-Out Resistance, and Proven Bio-Integration Performance WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., a fast-growing orthopedic fixation technology company, announced today the U.S. launch and first commercial use of OSSIOfiber® Suture Anchors, expanding patient access to the … [Read more…]

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, unveiled new shoulder sports medicine, arthroscopy and arthroplasty exacCoach™ message streams to connect more surgeons and patients throughout the journey of care. These expanded offerings build on the company’s powerful exacCoach patient text messaging platform that has … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Shingles Vaccine Market 2022-2031” report has been added to ResearchAndMarkets.com’s offering. The trade name of the shingles vaccine (recombinant zoster vaccine) is SHINGRIX, which was developed by GlaxoSmithKline. Its product was first approved in China in 2020. The Shingles vaccine is suitable for adults aged 50 years and over … [Read more…]

CLEVELAND–(BUSINESS WIRE)–$ATHX #ARS–Athersys, Inc. (Nasdaq: ATHX) announces today results of a radiation countermeasure study conducted by the Armed Forces Radiobiology Research Institute (AFRRI), a Department of Defense research laboratory under the leadership of the Uniformed Services University of the Health Sciences, that showed intravenous MultiStem® (invimestrocel) administration provided benefit in an animal model of acute … [Read more…]